PRF Technologies (PRFX) Profit After Tax (2020 - 2024)
PRF Technologies' (PRFX) quarterly Profit After Tax came in at $18.3 million in Q2 2024, up 740.17% YoY from $2.2 million in Q3 2023, and up 432.8% on a QoQ basis from -$5.5 million in Q1 2024.
PRF Technologies (PRFX) Profit After Tax (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Profit After Tax data on file, last reported at $18.3 million in Q2 2024.
- Quarterly Profit After Tax rose 740.17% year-over-year to $18.3 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$1.0 million (up 87.02% YoY) and the FY2025 annual result came in at -$5.0 million, up 65.57% from the prior year.
- Profit After Tax advanced to $18.3 million in Q2 2024, from -$5.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $18.3 million in Q2 2024 to a low of -$14.4 million in Q4 2022.
- A 5-year average of -$923166.7 and a median of $1.2 million in 2020 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax tumbled 523.99% — and 2024, when it surged 740.17%.
- Tracing PRFX's Profit After Tax over 5 years: stood at -$7.1 million in 2020, then tumbled by 79.58% to -$12.8 million in 2021, then slipped by 13.0% to -$14.4 million in 2022, then jumped by 66.08% to -$4.9 million in 2023, then jumped by 474.65% to $18.3 million in 2024.
- The last three Profit After Tax figures came in at $18.3 million (Q2 2024), -$5.5 million (Q1 2024), and -$4.9 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 18.32 Mn |
| Mar 31, 2024 | -5.51 Mn |
| Dec 31, 2023 | -4.89 Mn |
| Sep 30, 2023 | -8.94 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | -14.42 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 5.21 Mn |
| Mar 31, 2022 | -1.69 Mn |
| Dec 31, 2021 | -12.76 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.70 Mn |
| Mar 31, 2021 | 2.04 Mn |
| Dec 31, 2020 | -7.11 Mn |
| Sep 30, 2020 | 1.09 Mn |
| Jun 30, 2020 | 667,000.00 |
| Mar 31, 2020 | 1.30 Mn |